Oligochitosan polyplexes as carriers for retinal gene delivery

European Journal of Pharmaceutical Sciences

Volumn 48, Issue 1-2, 2013, Pages 323-331

  Puras, G ^a,b   Zarate, J ^a,b   Diaz Tahoces A ^b,c   Avilés Trigueros, Marcelino ^d   Fernandez E ^b,c   Pedraz, J L ^a,b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^d UNIVERSITY OF MURCIA   (Spain)

Author keywords

Gene delivery; Low molecular weight chitosan; Non viral gene therapy; Polyplexes; Retina

Indexed keywords

CHITOSAN; DNA; ENHANCED GREEN FLUORESCENT PROTEIN; OLIGOCHITOSAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; EMBRYO; ENZYME METABOLISM; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; MOLECULAR WEIGHT; NERVE CELL; NONHUMAN; NONVIRAL GENE THERAPY; PHOTORECEPTOR; PIGMENT CELL; PLASMID; PRIORITY JOURNAL; RAT; RETINA DISEASE; SUBRETINAL FLUID;

ANIMALS; CELL LINE; CHITIN; DNA; GENETIC THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; MALE; PLASMIDS; RATS; RATS, SPRAGUE-DAWLEY; RETINA;

EID: 84871453561     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.11.009     Document Type: Article

References (42)

1. M. Alatorre-Meda, P. Taboada, F. Hartl, T. Wagner, M. Freis, and J.R. Rodriguez The influence of chitosan valence on the complexation and transfection of DNA: the weaker the DNA-chitosan binding the higher the transfection efficiency Colloids Surf. B 82 2011 54 62
2. J.W. Bainbridge, A.J. Smith, S.S. Barker, S. Robbie, R. Henderson, K. Balaggan, A. Viswanathan, G.E. Holder, A. Stockman, N. Tyler, S. Petersen-Jones, S.S. Bhattacharya, A.J. Thrasher, F.W. Fitzke, B.J. Carter, G.S. Rubin, A.T. Moore, and R.R. Ali Effect of gene therapy on visual function in Leber's congenital amaurosis N. Engl. J. Med. 358 2008 2231 2239
3. S. Bassnett, and G. Duncan Direct measurement of pH in the rat lens by ion-sensitive microelectrodes Exp. Eye Res. 40 1985 585 590
4. R.A. Bejjani, D. BenEzra, H. Cohen, J. Rieger, C. Andrieu, J.C. Jeanny, G. Gollomb, and F.F. Behar-Cohen Nanoparticles for gene delivery to retinal pigment epithelial cells Mol. Vis. 11 2005 124 132
5. M. Bivas-Benita, S. Romeijn, H.E. Junginger, and G. Borchard PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium Eur. J. Pharm. Biopharm. 58 2004 1 6
6. X. Cai, S.M. Conley, Z. Nash, S.J. Fliesler, M.J. Cooper, and M.I. Naash Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa FASEB J. 24 2010 1178 1191
7. P. Charbel Issa, and R.E. MacLaren Non-viral retinal gene therapy: a review Clin. Experiment Ophthalmol. 40 2012 39 47
8. A.V. Cideciyan, T.S. Aleman, S.L. Boye, S.B. Schwartz, S. Kaushal, A.J. Roman, J.J. Pang, A. Sumaroka, E.A. Windsor, J.M. Wilson, T.R. Flotte, G.A. Fishman, E. Heon, E.M. Stone, B.J. Byrne, S.G. Jacobson, and W.W. Hauswirth Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics Proc. Natl. Acad. Sci. USA 105 2008 15112 15117
9. S.J. Clark, T.D. Keenan, H.L. Fielder, L.J. Collinson, R.J. Holley, C.L. Merry, T.H. van Kuppevelt, A.J. Day, and P.N. Bishop Mapping the differential distribution of glycosaminoglycans in the adult human retina, choroid, and sclera Invest. Ophthalmol. Vis. Sci. 52 2011 6511 6521
10. S.M. Conley, and M.I. Naash Nanoparticles for retinal gene therapy Prog. Retin Eye Res. 29 2010 376 397
11. S. Danielsen, K.M. Varum, and B.T. Stokke Structural analysis of chitosan mediated DNA condensation by AFM: influence of chitosan molecular parameters Biomacromolecules 5 2004 928 936
12. A. del Pozo-Rodriguez, D. Delgado, M.A. Solinis, A.R. Gascon, and J.L. Pedraz Solid lipid nanoparticles for retinal gene therapy: transfection and intracellular trafficking in RPE cells Int. J. Pharm. 360 2008 177 183
13. D. Delgado, A. Del Pozo-Rodriguez, M.A. Solinis, M. Aviles, B.H. Weber, E. Fernandez, and A. Rodriguez Gascon Dextran and protamine-based solid lipid nanoparticles as potential vectors for the treatment of X linked juvenile retinoschisis Hum. Gene. Ther. 2012
14. M. Dezawa, M. Takano, H. Negishi, X. Mo, T. Oshitari, and H. Sawada Gene transfer into retinal ganglion cells by in vivo electroporation: a new approach Micron 33 2002 1 6
15. R. Dias, F. Antunes, M. Miguel, S. Lindman, and B. Lindman DNA-lipid systems. A physical chemistry study Braz. J. Med. Biol. Res. 35 2002 509 522
16. Y. Diebold, and M. Calonge Applications of nanoparticles in ophthalmology Prog. Retin Eye Res. 29 2010 596 609
17. P. Dureau, L. Legat, M. Neuner-Jehle, S. Bonnel, S. Pecqueur, M. Abitbol, and J.L. Dufier Quantitative analysis of subretinal injections in the rat Graefes Arch. Clin. Exp. Ophthalmol. 238 2000 608 614
18. A.O. Edwards, R. Ritter 3rd, K.J. Abel, A. Manning, C. Panhuysen, and L.A. Farrer Complement factor H polymorphism and age-related macular degeneration Science 308 2005 421 424
19. C.L. Gebhart, and A.V. Kabanov Evaluation of polyplexes as gene transfer agents J. Controlled Release 73 2001 401 416
20. C.M. Gorman, M. Aikawa, B. Fox, E. Fox, C. Lapuz, B. Michaud, H. Nguyen, E. Roche, T. Sawa, and J.P. Wiener-Kronish Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid EDMPC Gene. Ther. 4 1997 983 992
21. W.W. Hauswirth, T.S. Aleman, S. Kaushal, A.V. Cideciyan, S.B. Schwartz, L. Wang, T.J. Conlon, S.L. Boye, T.R. Flotte, B.J. Byrne, and S.G. Jacobson Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial Hum. Gene. Ther. 19 2008 979 990
22. M. Huang, C.W. Fong, E. Khor, and L.Y. Lim Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation J. Controlled Release 106 2005 391 406
23. M. Jafari, M. Soltani, S. Naahidi, D.N. Karunaratne, and P. Chen Nonviral approach for targeted nucleic acid delivery Curr. Med. Chem. 19 2012 197 208
24. D.H. Jo, T.G. Lee, and J.H. Kim Nanotechnology and nanotoxicology in retinopathy Int. J. Mol. Sci. 12 2011 8288 8301
25. L.N. Johnson, S.M. Cashman, and R. Kumar-Singh Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea Mol. Ther. 16 2008 107 114
26. T. Kiang, J. Wen, H.W. Lim, and K.W. Leong The effect of the degree of chitosan deacetylation on the efficiency of gene transfection Biomaterials 25 2004 5293 5301
27. E.A. Klausner, Z. Zhang, R.L. Chapman, R.F. Multack, and M.V. Volin Ultrapure chitosan oligomers as carriers for corneal gene transfer Biomaterials 31 2010 1814 1820
28. E.A. Klausner, Z. Zhang, S.P. Wong, R.L. Chapman, M.V. Volin, and R.P. Harbottle Corneal gene delivery: chitosan oligomer as a carrier of CpG rich, CpG free, or S/MAR plasmid DNA J. Gene. Med. 14 2012 100 108
29. M. Koping-Hoggard, I. Tubulekas, H. Guan, K. Edwards, M. Nilsson, K.M. Varum, and P. Artursson Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo Gene. Ther. 8 2001 1108 1121
30. M. Koping-Hoggard, Y.S. Mel'nikova, K.M. Varum, B. Lindman, and P. Artursson Relationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo J. Gene. Med. 5 2003 130 141
31. J.Y. Lai, Y.T. Li, and T.P. Wang In vitro response of retinal pigment epithelial cells exposed to chitosan materials prepared with different cross-linkers Int. J. Mol. Sci. 11 2010 5256 5272
32. M. Lee, J.W. Nah, Y. Kwon, J.J. Koh, K.S. Ko, and S.W. Kim Water-soluble and low molecular weight chitosan-based plasmid DNA delivery Pharm. Res. 18 2001 427 431
33. M.M. Liu, J. Tuo, and C.C. Chan Gene therapy for ocular diseases Br. J. Ophthalmol. 95 2011 604 612
34. A.M. Maguire, F. Simonelli, E.A. Pierce, E.N. Pugh Jr.; F. Mingozzi, J. Bennicelli, S. Banfi, K.A. Marshall, F. Testa, E.M. Surace, S. Rossi, A. Lyubarsky, V.R. Arruda, B. Konkle, E. Stone, J. Sun, J. Jacobs, L. Dell'Osso, R. Hertle, J.X. Ma, T.M. Redmond, X. Zhu, B. Hauck, O. Zelenaia, K.S. Shindler, M.G. Maguire, J.F. Wright, N.J. Volpe, J.W. McDonnell, A. Auricchio, K.A. High, and J. Bennett Safety and efficacy of gene transfer for Leber's congenital amaurosis N. Engl. J. Med. 358 2008 2240 2248
35. H.Q. Mao, K. Roy, V.L. Troung-Le, K.A. Janes, K.Y. Lin, Y. Wang, J.T. August, and K.W. Leong Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency J. Controlled Release 70 2001 399 421
36. G. Maurstad, S. Danielsen, and B.T. Stokke The influence of charge density of chitosan in the compaction of the polyanions DNA and xanthan Biomacromolecules 8 2007 1124 1130
37. S. Nimesh, M.M. Thibault, M. Lavertu, and M.D. Buschmann Enhanced gene delivery mediated by low molecular weight chitosan/DNA complexes: effect of pH and serum Mol. Biotechnol. 46 2010 182 196
38. R.B. Nussenblatt, and K. Csaky Perspectives on gene therapy in the treatment of ocular inflammation Eye (Lond.) 11 Pt 2 1997 217 221
39. T.W. Prow, I. Bhutto, S.Y. Kim, R. Grebe, C. Merges, D.S. McLeod, K. Uno, M. Mennon, L. Rodriguez, K. Leong, and G.A. Lutty Ocular nanoparticle toxicity and transfection of the retina and retinal pigment epithelium Nanomedicine 4 2008 340 349
40. A. Rolland Gene medicines: the end of the beginning? Adv. Drug Deliv. Rev. 57 2005 669 673
41. T. Sato, T. Ishii, and Y. Okahata In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency Biomaterials 22 2001 2075 2080
42. Y. Zhang, F. Schlachetzki, J.Y. Li, R.J. Boado, and W.M. Pardridge Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer Mol. Vis. 9 2003 465 472